Worst performing IPOs in the U.S. 2018

The statistic shows the worst performing IPOs of 2018 in the United States, by rate of return from the company IPO until the end of 2018. The stock price of Genprex, a company operating in the health care sector, sold publicly the first time on March 28, 2018, had fallen by 78.0 percent by the end of 2018.

IPOs with lowest return in the United States in 2018

Return since the company IPO date until the end of 2018
Genprex (Mar 28)-70%
EverQuote (Jun 27)-76.8%
Menlo Therapeutics (Jan 23)-75.8%
Sunlands Online Education (Mar 22)-73.6%
Constellation Pharmaceuticals (Jul 18)-73.3%
Entasis Therapeutics (Sep 25)-72.9%
Surface Oncology (Apr 18)-71.7%
Eyenovia (Jan 24)-71.5%
Hancock Jaffe Laboratories (May 30)-70.5%
Vaccinex (Aug 9)-69.6%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2019


United States

Survey time period


Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Initial public offerings in the United States"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.